HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of NIP-142 on potassium channel alpha-subunits Kv1.5, Kv4.2 and Kv4.3, and mouse atrial repolarization.

Abstract
Effects of NIP-142, a benzopyran compound which terminates experimental atrial arrhythmia, on potassium channel alpha-subunits and mouse atrial repolarization were examined. NIP-142 concentration-dependently blocked the outward current through potassium channel alpha subunits Kv1.5, Kv4.2 and Kv4.3 expressed in Xenopus oocytes. In isolated mouse atrial myocardia, NIP-142 prolonged the action potential duration and effective refractory period, and increased the contractile force. These results suggest that NIP-142 blocks the potassium channels underlying the transient and sustained outward currents, which may contribute to its antiarrhythmic activity.
AuthorsHikaru Tanaka, Iyuki Namekata, Shogo Hamaguchi, Taro Kawamura, Hiroyuki Masuda, Yoshio Tanaka, Naoko Iida-Tanaka, Akira Takahara
JournalBiological & pharmaceutical bulletin (Biol Pharm Bull) Vol. 33 Issue 1 Pg. 138-41 ( 2010) ISSN: 1347-5215 [Electronic] Japan
PMID20045952 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Arrhythmia Agents
  • Benzopyrans
  • NIP142
  • Shaker Superfamily of Potassium Channels
Topics
  • Action Potentials (drug effects)
  • Animals
  • Anti-Arrhythmia Agents (pharmacology, therapeutic use)
  • Atrial Fibrillation (drug therapy)
  • Benzopyrans (pharmacology, therapeutic use)
  • Dose-Response Relationship, Drug
  • Heart Atria (drug effects)
  • Mice
  • Muscle Contraction (drug effects)
  • Myocardium (chemistry)
  • Oocytes
  • Shaker Superfamily of Potassium Channels (antagonists & inhibitors)
  • Xenopus

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: